Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending September 15, 2019 No Alterations of Brain Structural Asymmetry in MDD, Gender Disparity in Risk of Hypertension in Patients with MDD, Burden of Comorbidities in Major Depressive Disorder, MDD With Insomnia Shows High Daytime Dysfunction, Ratio of Plasma BDNF To Leptin Levels in MDD, More must reads Must reads for theWeek ending September 8, 2019 New study confirms rise in U.S. suicide rates, particularly in rural areas, More must readsMust reads for theWeek ending September 1, 2019 Genetic Cohort Supports NfL as Alzheimer’s Biomarker, Genotype may affect lifestyle’s influence on dementia risk, Pharmacist Stigma a Barrier to Rural Buprenorphine Access, White Matter Deficits Increase Risk of Treatment Resistance in Schizophrenia, Patients With Schizophrenia at Higher Risk of Smoking-Related Illnesses, More must readsMust reads for theWeek ending August 25, 2019 PTSD symptom reduction tied to lower risk of type 2 diabetes, Cigarette Smoking in Schizophrenia, Quality of Life in Patients with Schizophrenia, Measuring Remission in Schizophrenia, Working Memory Impairments in Schizophrenia, More must readsMust reads for theWeek ending August 18, 2019 Cognitive Change in Schizophrenia After First Episode, Meaningful Use of EHRs and Health Outcomes in Schizophrenia, Individual Treatment Response in Schizophrenia , Cardiac Function in Patients With Schizophrenia, Optimal Length of Hospitalization for Patients With Schizophrenia, More must readsPages« first 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 last »
